Aug 14, 2026 08:00AM
Aug 14, 2026 08:00AM
Jul 7, 2026 08:03AM
Jul 7, 2026 08:00AM
Jun 30, 2026 08:01AM
Jun 30, 2026 08:00AM
Jun 18, 2026 08:00AM Allarity to present stenoparib Phase 2 poster at ESMO congress
Jun 18, 2026 08:00AM
May 15, 2026 04:30PM
May 5, 2026 08:00AM
May 5, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 21, 2026 08:02AM Allarity presents cancer drug data at AACR conference
Apr 21, 2026 08:00AM
Mar 31, 2026 08:00AM
Mar 31, 2026 08:00AM
Mar 6, 2026 08:01AM
Mar 6, 2026 08:00AM
Mar 6, 2026 08:00AM
Mar 6, 2026 08:00AM Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization
Feb 18, 2026 08:15AM
Feb 18, 2026 08:15AM
Feb 3, 2026 08:00AM
Feb 3, 2026 08:00AM
Dec 31, 2025 08:00AM
Nov 14, 2025 09:00AM
Sep 22, 2025 08:01AM Allarity reports median survival exceeds 25 months in ovarian cancer trial
Sep 22, 2025 08:00AM
Aug 26, 2025 08:00AM
Aug 26, 2025 08:00AM
Jun 2, 2025 08:00AM
Jun 2, 2025 08:00AM
May 9, 2025 04:05PM
Apr 25, 2025 08:01AM Allarity Therapeutics (ALLR) Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025
Apr 25, 2025 08:00AM
Mar 31, 2025 04:05PM
Mar 13, 2025 08:33AM
Mar 13, 2025 08:30AM
Mar 6, 2025 08:00AM
Feb 24, 2025 08:00AM
Feb 6, 2025 08:01AM Allarity Therapeutics (ALLR) Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer
Feb 6, 2025 08:00AM
Jan 30, 2025 08:06AM
Jan 30, 2025 08:00AM
Nov 18, 2024 08:03AM
Nov 18, 2024 08:00AM
Nov 14, 2024 08:00AM
Oct 18, 2024 12:47PM Allarity Therapeutics, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court fo
Jul 22, 2024 06:32AM

330,211 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All